References
(1) GOULD, E. A.; WINSHIP, T.; PHILBIN, P. H.; KERR, H. H. Observations on a ”sentinel node” in cancer of the parotid. Cancer1960 , 13 , 77-78. DOI: 10.1002/1097-0142(196001/02)13:1<77::aid-cncr2820130114>3.0.co;2-d.
(2) Abu-Rustum, N. R. Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. J Natl Compr Canc Netw 2014 , 12 (2), 288-297. DOI: 10.6004/jnccn.2014.0026.
(3) Cabanas, R. M. An approach for the treatment of penile carcinoma.Cancer 1977 , 39 (2), 456-466. DOI: 10.1002/1097-0142(197702)39:2<456::aid-cncr2820390214>3.0.co;2-i.
(4) Giuliano, A. E.; Ballman, K. V.; McCall, L.; Beitsch, P. D.; Brennan, M. B.; Kelemen, P. R.; Ollila, D. W.; Hansen, N. M.; Whitworth, P. W.; Blumencranz, P. W.; et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 2017 ,318 (10), 918-926. DOI: 10.1001/jama.2017.11470.
(5) Faries, M. B.; Thompson, J. F.; Cochran, A. J.; Andtbacka, R. H.; Mozzillo, N.; Zager, J. S.; Jahkola, T.; Bowles, T. L.; Testori, A.; Beitsch, P. D.; et al. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med 2017 ,376 (23), 2211-2222. DOI: 10.1056/NEJMoa1613210.
(6) Burke, T. W.; Levenback, C.; Tornos, C.; Morris, M.; Wharton, J. T.; Gershenson, D. M. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol1996 , 62 (2), 169-173. DOI: 10.1006/gyno.1996.0211.
(7) Lu, K. H.; Broaddus, R. R. Endometrial Cancer. N Engl J Med2020 , 383 (21), 2053-2064. DOI: 10.1056/NEJMra1514010.
(8) Benedetti Panici, P.; Basile, S.; Maneschi, F.; Alberto Lissoni, A.; Signorelli, M.; Scambia, G.; Angioli, R.; Tateo, S.; Mangili, G.; Katsaros, D.; et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008 , 100(23), 1707-1716. DOI: 10.1093/jnci/djn397.
(9) Kitchener, H.; Swart, A. M.; Qian, Q.; Amos, C.; Parmar, M. K.; group, A. s. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet2009 , 373 (9658), 125-136. DOI: 10.1016/S0140-6736(08)61766-3.
(10) Rossi, E. C.; Kowalski, L. D.; Scalici, J.; Cantrell, L.; Schuler, K.; Hanna, R. K.; Method, M.; Ade, M.; Ivanova, A.; Boggess, J. F. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017 , 18 (3), 384-392. DOI: 10.1016/S1470-2045(17)30068-2.
(11) Holloway, R. W.; Abu-Rustum, N. R.; Backes, F. J.; Boggess, J. F.; Gotlieb, W. H.; Jeffrey Lowery, W.; Rossi, E. C.; Tanner, E. J.; Wolsky, R. J. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. Gynecol Oncol 2017 , 146 (2), 405-415. DOI: 10.1016/j.ygyno.2017.05.027.
(12) Papadia, A.; Gasparri, M. L.; Buda, A.; Mueller, M. D. Sentinel lymph node mapping in endometrial cancer: comparison of fluorescence dye with traditional radiocolloid and blue. J Cancer Res Clin Oncol2017 , 143 (10), 2039-2048. DOI: 10.1007/s00432-017-2501-8.
(13) Wang, Y.; Dan, Z.; Yuan, G.; Zhang, G.; Liu, S.; Zhang, Y.; Li, B. Detection of sentinel lymph node in laparoscopic surgery for uterine cervical cancer using carbon nanoparticles. J Surg Oncol2020 , 122 (5), 934-940. DOI: 10.1002/jso.26100.
(14) Manca, G.; Garau, L. M.; Mazzarri, S.; Mazzuca, L.; Muccioli, S.; Ghilli, M.; Naccarato, G.; Colletti, P. M.; Rubello, D.; Roncella, M.; et al. Novel Experience in Hybrid Tracers: Clinical Evaluation of Feasibility and Efficacy in Using ICG-99mTc Nanotop for Sentinel Node Procedure in Breast Cancer Patients. Clin Nucl Med 2021 ,46 (4), e181-e187. DOI: 10.1097/RLU.0000000000003478.
(15) Hou, H.; Dai, Y.; Liang, S.; Wang, Z.; Wang, J. Sentinel Lymph Node Biopsy Is Feasible in Cervical Cancer Laparoscopic Surgery: A Single-Center Retrospective Cohort Study. J Oncol 2021 ,2021 , 5510623. DOI: 10.1155/2021/5510623.
(16) How, J.; Gotlieb, W. H.; Press, J. Z.; Abitbol, J.; Pelmus, M.; Ferenczy, A.; Probst, S.; Gotlieb, R.; Brin, S.; Lau, S. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. Gynecol Oncol 2015 ,137 (3), 436-442. DOI: 10.1016/j.ygyno.2015.04.004.
(17) Darin, M. C.; Gómez-Hidalgo, N. R.; Westin, S. N.; Soliman, P. T.; Escobar, P. F.; Frumovitz, M.; Ramirez, P. T. Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard? J Minim Invasive Gynecol 2016 ,23 (2), 186-193. DOI: 10.1016/j.jmig.2015.10.011.
(18) Backes, F. J.; Cohen, D.; Salani, R.; Cohn, D. E.; O’Malley, D. M.; Fanning, E.; Suarez, A. A.; Fowler, J. M. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739). Gynecol Oncol 2019 ,153 (3), 496-499. DOI: 10.1016/j.ygyno.2019.03.252.
(19) Kim, J. H.; Ku, M.; Yang, J.; Byeon, H. K. Recent Developments of ICG-Guided Sentinel Lymph Node Mapping in Oral Cancer. Diagnostics (Basel) 2021 , 11 (5). DOI: 10.3390/diagnostics11050891.
(20) Egloff-Juras, C.; Bezdetnaya, L.; Dolivet, G.; Lassalle, H. P. NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green. Int J Nanomedicine 2019 , 14 , 7823-7838. DOI: 10.2147/IJN.S207486.
(21) Papadia, A.; Gasparri, M. L.; Radan, A. P.; Stämpfli, C. A. L.; Rau, T. T.; Mueller, M. D. Retrospective validation of the laparoscopic ICG SLN mapping in patients with grade 3 endometrial cancer. J Cancer Res Clin Oncol 2018 , 144 (7), 1385-1393. DOI: 10.1007/s00432-018-2648-y.
(22) Body, N.; Grégoire, J.; Renaud, M. C.; Sebastianelli, A.; Grondin, K.; Plante, M. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer. Gynecol Oncol2018 , 150 (2), 267-273. DOI: 10.1016/j.ygyno.2018.06.001.
(23) Biliatis, I.; Thomakos, N.; Koutroumpa, I.; Haidopoulos, D.; Sotiropoulou, M.; Antsaklis, A.; Vlachos, G.; Akrivos, N.; Rodolakis, A. Subserosal uterine injection of blue dye for the identification of the sentinel node in patients with endometrial cancer: a feasibility study.Arch Gynecol Obstet 2017 , 296 (3), 565-570. DOI: 10.1007/s00404-017-4468-8.
(24) Gien, L. T.; Kwon, J. S.; Carey, M. S. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J Obstet Gynaecol Can2005 , 27 (12), 1107-1112. DOI: 10.1016/s1701-2163(16)30393-0.
(25) Aurich, S.; Seitz, A. T.; Tomm, J.; Simon, J. C.; Treudler, R. A Case of Anaphylaxis to Patent Blue in a Patient with Sentinel Lymph Node Excision. Iran J Allergy Asthma Immunol 2016 , 15(6), 547-550.
(26) Cinar, H.; Koca, B.; Kesicioglu, T.; Karabulut, K.; Karabicak, I.; Polat, C.; Tur, A. H. Isosulfan blue-induced anaphylactic reaction during sentinel lymph node biopsy in breast cancer. Breast2012 , 21 (2), 220-222. DOI: 10.1016/j.breast.2011.11.008.
(27) Momeni, R.; Ariyan, S. Pulse oximetry declines due to intradermal isosulfan blue dye: a controlled prospective study. Ann Surg Oncol 2004 , 11 (4), 434-437. DOI: 10.1245/ASO.2004.05.015.
(28) Zhai, L.; Zhang, X.; Cui, M.; Wang, J. Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review. Front Oncol2021 , 11 , 701758. DOI: 10.3389/fonc.2021.701758.
(29) Nagar, H.; Wietek, N.; Goodall, R. J.; Hughes, W.; Schmidt-Hansen, M.; Morrison, J. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer. Cochrane Database Syst Rev2021 , 6 , CD013021. DOI: 10.1002/14651858.CD013021.pub2.
(30) van den Berg, N. S.; Brouwer, O. R.; Klop, W. M.; Karakullukcu, B.; Zuur, C. L.; Tan, I. B.; Balm, A. J.; van den Brekel, M. W.; Valdés Olmos, R. A.; van Leeuwen, F. W. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging 2012 , 39 (7), 1128-1136. DOI: 10.1007/s00259-012-2129-5.
(31) Liu, S.; Wang, H.; Zhang, C.; Dong, J.; Xu, R.; Tian, C. In Vivo Photoacoustic Sentinel Lymph Node Imaging Using Clinically-Approved Carbon Nanoparticles. IEEE Trans Biomed Eng 2020 ,67 (7), 2033-2042. DOI: 10.1109/TBME.2019.2953743.
(32) Jiang, Y.; Lin, N.; Huang, S.; Lin, C.; Jin, N.; Zhang, Z.; Ke, J.; Yu, Y.; Zhu, J.; Wang, Y. Tracking nonpalpable breast cancer for breast-conserving surgery with carbon nanoparticles: implication in tumor location and lymph node dissection. Medicine (Baltimore)2015 , 94 (10), e605. DOI: 10.1097/MD.0000000000000605.
(33) Wang, L.; Yang, D.; Lv, J. Y.; Yu, D.; Xin, S. J. Application of carbon nanoparticles in lymph node dissection and parathyroid protection during thyroid cancer surgeries: a systematic review and meta-analysis.Onco Targets Ther 2017 , 10 , 1247-1260. DOI: 10.2147/OTT.S131012.
(34) Liang, S.; Wang, Z.; Chen, J.; Yang, X.; Liang, X.; Sun, X.; Li, X.; Zhou, R.; Li, Y.; Wang, J. Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma. J Surg Oncol 2021 , 124 (3), 411-419. DOI: 10.1002/jso.26518.
(35) Liu, P.; Tan, J.; Tan, Q.; Xu, L.; He, T.; Lv, Q. Application of Carbon Nanoparticles in Tracing Lymph Nodes and Locating Tumors in Colorectal Cancer: A Concise Review. Int J Nanomedicine2020 , 15 , 9671-9681. DOI: 10.2147/IJN.S281914.
(36) Tardelli, E.; Mazzarri, S.; Rubello, D.; Gennaro, M.; Fantechi, L.; Duce, V.; Romanini, A.; Chondrogiannis, S.; Volterrani, D.; Colletti, P. M.; et al. Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature. Clin Nucl Med 2016 , 41 (12), e498-e507. DOI: 10.1097/RLU.0000000000001370.
(37) Zivanovic, O.; Khoury-Collado, F.; Abu-Rustum, N. R.; Gemignani, M. L. Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer. Oncologist2009 , 14 (7), 695-705. DOI: 10.1634/theoncologist.2009-0075.
(38) Eriksson, A. G. Z.; Davidson, B.; Bjerre Trent, P.; Eyjólfsdóttir, B.; Dahl, G. F.; Wang, Y.; Staff, A. C. Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma. J Clin Med2021 , 10 (14). DOI: 10.3390/jcm10143094.
(39) Niikura, H.; Kaiho-Sakuma, M.; Tokunaga, H.; Toyoshima, M.; Utsunomiya, H.; Nagase, S.; Takano, T.; Watanabe, M.; Ito, K.; Yaegashi, N. Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol2013 , 131 (2), 299-303. DOI: 10.1016/j.ygyno.2013.08.018.
(40) Brooks, R. A.; Fleming, G. F.; Lastra, R. R.; Lee, N. K.; Moroney, J. W.; Son, C. H.; Tatebe, K.; Veneris, J. L. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin2019 , 69 (4), 258-279. DOI: 10.3322/caac.21561.
(41) Ditto, A.; Casarin, I.; Pinelli, C.; Perrone, A. M.; Scollo, P.; Martinelli, F.; Bogani, G.; Leone Roberti Maggiore, U.; Signorelli, M.; Chiappa, V.; et al. Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group. Eur J Cancer 2020 ,140 , 1-10. DOI: 10.1016/j.ejca.2020.08.030.
(42) Angeles, M. A.; Migliorelli, F.; Vidal-Sicart, S.; Saco, A.; Ordi, J.; Ros, C.; Fusté, P.; Munmany, M.; Escura, S.; Carreras, N.; et al. Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR). J Gynecol Oncol 2021 ,32 (4), e52. DOI: 10.3802/jgo.2021.32.e52.
(43) Perrone, A. M.; Casadio, P.; Formelli, G.; Levorato, M.; Ghi, T.; Costa, S.; Meriggiola, M. C.; Pelusi, G. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol Oncol 2008 , 111 (1), 62-67. DOI: 10.1016/j.ygyno.2008.05.032.
(44) Mücke, J.; Klapdor, R.; Schneider, M.; Länger, F.; Gratz, K. F.; Hillemanns, P.; Hertel, H. Isthmocervical labelling and SPECT/CT for optimized sentinel detection in endometrial cancer: technique, experience and results. Gynecol Oncol 2014 , 134(2), 287-292. DOI: 10.1016/j.ygyno.2014.05.001.
(45) Ruiz, R.; Gorostidi, M.; Jaunarena, I.; Cobas, P.; Lekuona, A. Maximizing sentinel node detection in endometrial cancer with dual cervical and transcervical fundal indocyanine green injection: 5-year single-center prospective study. Eur J Obstet Gynecol Reprod Biol2021 , 261 , 59-64. DOI: 10.1016/j.ejogrb.2021.04.015.
(46) Barlin, J. N.; Khoury-Collado, F.; Kim, C. H.; Leitao, M. M.; Chi, D. S.; Sonoda, Y.; Alektiar, K.; DeLair, D. F.; Barakat, R. R.; Abu-Rustum, N. R. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol 2012 , 125 (3), 531-535. DOI: 10.1016/j.ygyno.2012.02.021.
(47) Geppert, B.; Lönnerfors, C.; Bollino, M.; Arechvo, A.; Persson, J. A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecol Oncol 2017 , 145 (2), 256-261. DOI: 10.1016/j.ygyno.2017.02.018.
(48) Levenback, C. F. Status of sentinel lymph node biopsy in gynecological cancers. Ann Surg Oncol 2008 , 15(1), 18-20. DOI: 10.1245/s10434-007-9516-3.
(49) Dabi, Y.; Bendifallah, S.; Kolanska, K.; Boudy, A. S.; Querleu, D.; Akladios, C.; Zilberman, S.; Darai, E.; Touboul, C. Anatomical basis of lymph node detection in gynecologic cancers: a review from a surgical perspective. Chin Clin Oncol 2021 , 10 (2), 15. DOI: 10.21037/cco-20-228.
(50) Persson, J.; Geppert, B.; Lönnerfors, C.; Bollino, M.; Måsbäck, A. Description of a reproducible anatomically based surgical algorithm for detection of pelvic sentinel lymph nodes in endometrial cancer.Gynecol Oncol 2017 , 147 (1), 120-125. DOI: 10.1016/j.ygyno.2017.07.131.
(51) Bollino, M.; Geppert, B.; Lönnerfors, C.; Falconer, H.; Salehi, S.; Persson, J. Pelvic sentinel lymph node biopsy in endometrial cancer-a simplified algorithm based on histology and lymphatic anatomy. Int J Gynecol Cancer 2020 , 30 (3), 339-345. DOI: 10.1136/ijgc-2019-000935.
(52) Abu-Rustum, N. R.; Yashar, C. M.; Bradley, K.; Campos, S. M.; Chino, J.; Chon, H. S.; Chu, C.; Cohn, D.; Crispens, M. A.; Damast, S.; et al. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.J Natl Compr Canc Netw 2021 , 19 (8), 888-895. DOI: 10.6004/jnccn.2021.0038.
(53) Cibula, D.; Abu-Rustum, N. R.; Dusek, L.; Slama, J.; Zikán, M.; Zaal, A.; Sevcik, L.; Kenter, G.; Querleu, D.; Jach, R.; et al. Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol 2012 , 127 (3), 462-466. DOI: 10.1016/j.ygyno.2012.08.035.
(54) Kim, C. H.; Soslow, R. A.; Park, K. J.; Barber, E. L.; Khoury-Collado, F.; Barlin, J. N.; Sonoda, Y.; Hensley, M. L.; Barakat, R. R.; Abu-Rustum, N. R. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer 2013 , 23(5), 964-970. DOI: 10.1097/IGC.0b013e3182954da8.
(55) Multinu, F.; Casarin, J.; Cappuccio, S.; Keeney, G. L.; Glaser, G. E.; Cliby, W. A.; Weaver, A. L.; McGree, M. E.; Angioni, S.; Faa, G.; et al. Ultrastaging of negative pelvic lymph nodes to decrease the true prevalence of isolated paraaortic dissemination in endometrial cancer.Gynecol Oncol 2019 , 154 (1), 60-64. DOI: 10.1016/j.ygyno.2019.05.008.
(56) Koh, W. J.; Abu-Rustum, N. R.; Bean, S.; Bradley, K.; Campos, S. M.; Cho, K. R.; Chon, H. S.; Chu, C.; Cohn, D.; Crispens, M. A.; et al. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2018 , 16 (2), 170-199. DOI: 10.6004/jnccn.2018.0006.
(57) Altin, D.; Taskin, S.; Tokgozoglu, N.; Vatansever, D.; Guler, A. H.; Gungor, M.; Tasci, T.; Turan, H.; Kahramanoglu, I.; Yalcin, I.; et al. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004). J Surg Oncol 2021 , 123 (2), 638-645. DOI: 10.1002/jso.26310.
(58) Plante, M.; Stanleigh, J.; Renaud, M. C.; Sebastianelli, A.; Grondin, K.; Grégoire, J. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter? Gynecol Oncol 2017 , 146 (2), 240-246. DOI: 10.1016/j.ygyno.2017.05.024.
(59) Bogani, G.; Mariani, A.; Paolini, B.; Ditto, A.; Raspagliesi, F. Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells. Gynecol Oncol 2019 , 153(3), 670-675. DOI: 10.1016/j.ygyno.2019.02.027.
(60) St Clair, C. M.; Eriksson, A. G.; Ducie, J. A.; Jewell, E. L.; Alektiar, K. M.; Hensley, M. L.; Soslow, R. A.; Abu-Rustum, N. R.; Leitao, M. M. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma. Ann Surg Oncol 2016 , 23 (5), 1653-1659. DOI: 10.1245/s10434-015-5040-z.
(61) Ignatov, A.; Lebius, C.; Ignatov, T.; Ivros, S.; Knueppel, R.; Papathemelis, T.; Ortmann, O.; Eggemann, H. Lymph node micrometastases and outcome of endometrial cancer. Gynecol Oncol 2019 ,154 (3), 475-479. DOI: 10.1016/j.ygyno.2019.07.018.
(62) Colombo, N.; Creutzberg, C.; Amant, F.; Bosse, T.; González-Martín, A.; Ledermann, J.; Marth, C.; Nout, R.; Querleu, D.; Mirza, M. R.; et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol 2016 ,27 (1), 16-41. DOI: 10.1093/annonc/mdv484.
(63) Mathevet, P.; Lécuru, F.; Uzan, C.; Boutitie, F.; Magaud, L.; Guyon, F.; Querleu, D.; Fourchotte, V.; Baron, M.; Bats, A. S.; et al. Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2).Eur J Cancer 2021 , 148 , 307-315. DOI: 10.1016/j.ejca.2021.02.009.
(64) Sponholtz, S. E.; Mogensen, O.; Hildebrandt, M. G.; Schledermann, D.; Parner, E.; Markauskas, A.; Frøding, L. P.; Fuglsang, K.; Vilstrup, M. H.; Bjørnholt, S. M.; et al. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial). Gynecol Oncol 2021 , 162 (3), 546-554. DOI: 10.1016/j.ygyno.2021.06.018.
(65) Suidan, R. S.; Sun, C. C.; Cantor, S. B.; Mariani, A.; Soliman, P. T.; Westin, S. N.; Lu, K. H.; Giordano, S. H.; Meyer, L. A. Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-Effectiveness Analysis. Obstet Gynecol 2018 ,132 (1), 52-58. DOI: 10.1097/AOG.0000000000002677.
(66) Ye, L.; Li, S.; Lu, W.; He, Q.; Li, Y.; Li, B.; Wang, X.; Yan, Q.; Wan, X. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?Oncologist 2019 , 24 (12), e1381-e1387. DOI: 10.1634/theoncologist.2019-0113.
(67) Marchocki, Z.; Cusimano, M. C.; Clarfield, L.; Kim, S. R.; Fazelzad, R.; Espin-Garcia, O.; Bouchard-Fortier, G.; Rossi, E. C.; Stewart, K. I.; Soliman, P. T.; et al. Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. Am J Obstet Gynecol 2021 ,225 (4), 367.e361-367.e339. DOI: 10.1016/j.ajog.2021.05.034.
(68) Gu, Y.; Cheng, H.; Zong, L.; Kong, Y.; Xiang, Y. Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis With Trial Sequential Analysis. Front Oncol 2020 , 10 , 580128. DOI: 10.3389/fonc.2020.580128.
(69) Cusimano, M. C.; Vicus, D.; Pulman, K.; Maganti, M.; Bernardini, M. Q.; Bouchard-Fortier, G.; Laframboise, S.; May, T.; Hogen, L. F.; Covens, A. L.; et al. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging. JAMA Surg 2021 , 156 (2), 157-164. DOI: 10.1001/jamasurg.2020.5060.
(70) Geppert, B.; Lönnerfors, C.; Bollino, M.; Persson, J. Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications. Gynecol Oncol 2018 , 148(3), 491-498. DOI: 10.1016/j.ygyno.2017.12.017.
(71) Buda, A.; Di Martino, G.; Restaino, S.; De Ponti, E.; Monterossi, G.; Giuliani, D.; Ercoli, A.; Dell’Orto, F.; Dinoi, G.; Grassi, T.; et al. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers. Gynecol Oncol2017 , 147 (3), 528-534. DOI: 10.1016/j.ygyno.2017.09.033.
(72) Zahl Eriksson, A. G.; Ducie, J.; Ali, N.; McGree, M. E.; Weaver, A. L.; Bogani, G.; Cliby, W. A.; Dowdy, S. C.; Bakkum-Gamez, J. N.; Abu-Rustum, N. R.; et al. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol 2016 , 140 (3), 394-399. DOI: 10.1016/j.ygyno.2015.12.028.